NEW YORK, Oct. 29 — Agilent Technologies and Paradigm Genetics announced a deal on Monday to develop a microarray of the whole genome of Arabidopsis thaliana

Palo Alto, Calif.-based Agilent will design, manufacture, distribute and sell the microarray. Paradigm will provide gene function expertise. The two companies plan to have the product ready for market by the end of the year. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.